Biopredic
Biopredic International, founded in 1993 and part of the Wepredic Group, is a biotechnology company specializing in the manufacture of assay systems derived from human and animal biological materials. Serving both academic research and major industries in pharmaceuticals, chemicals, and cosmetics, Biopredic provides innovative in vitro models that contribute to the 3Rs approach—helping replace or reduce animal testing.
The company’s expertise is reflected in a broad portfolio covering multiple biological systems. In liver assay systems, Biopredic offers human and animal hepatocytes, the HepaRG™ cell model, HepaSH human hepatocytes, non-parenchymal liver cells, microsomes, cytosolic and S9 fractions, Silensomes™, and specialized cell culture reagents. Its skin assay systems include fresh and frozen skin sheets and discs, primary skin cells, and reagents tailored for dermal studies. For blood-based assays, the range covers human and animal whole blood, plasma, serum, and blood cells such as PBMCs. Biopredic also supplies renal, pulmonary, and intestinal tissues, cells, subcellular fractions, and culture reagents, broadening the scope of its in vitro testing solutions.
By combining scientific know-how with premium services, Biopredic International provides high-quality assay systems that enable researchers and industries to advance drug, cosmetic, and chemical development with accuracy, responsibility, and innovation.
